Back to Search
BERNARD CHAITMAN, MD
MD
Cardiovascular Disease Physician
NPI: 1326056292Individual
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
R8C62(MO)
Research & Publications (20)
When should ranolazine be considered for the treatment of chronic angina?
PMID 17063161·Nat Clin Pract Cardiovasc Med·2006
8-other
Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions.
PMID 16717165·Circulation·2006
6-review
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
PMID 14734593·JAMA·2004
3-trial
An electrocardiogram should not be included in routine preparticipation screening of young athletes.
PMID 18040040·Circulation·2007
8-other
Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.
PMID 15378131·J Cardiovasc Pharmacol Ther·2004
4-observational
Measuring antianginal drug efficacy using exercise testing for chronic angina: improved exercise performance with ranolazine, a pFOX inhibitor.
PMID 12501118·Curr Probl Cardiol·2002
6-review
Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial.
PMID 19389561·J Am Coll Cardiol·2009
4-observational
Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial).
PMID 19576311·Am J Cardiol·2009
2-rct
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
PMID 19502645·N Engl J Med·2009
4-observational
Electrocardiography screening for cardiotoxicity after modified Vaccinia Ankara vaccination.
PMID 19114175·Am J Med·2009
2-rct
Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial.
PMID 19349325·Circulation·2009
4-observational
Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study.
PMID 18355507·Ann Thorac Surg·2008
4-observational
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
PMID 18268144·Circulation·2008
4-observational
Clinical and research issues regarding chronic advanced coronary artery disease: part I: Contemporary and emerging therapies.
PMID 18294474·Am Heart J·2008
6-review
Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues.
PMID 18294475·Am Heart J·2008
6-review
Task force 2: training in electrocardiography, ambulatory electrocardiography, and exercise testing.
PMID 18206751·J Am Coll Cardiol·2008
6-review
Novel therapeutic approaches to treating chronic angina in the setting of chronic ischemic heart disease.
PMID 18373327·Clin Cardiol·2007
6-review
Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge.
PMID 18036708·Vaccine·2007
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3660 VISTA
ST LOUIS, MO 63110 - Phone
- (314) 725-4668
Quick Facts
- NPI
- 1326056292
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile